BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2013
View Archived Issues
Identification of a unique series of small-molecule antiproliferative chromatin adaptor inhibitors
Read More
Evaluation of antibody-based delivery of IL-2 for the treatment of blood cancers
Read More
A priming dendritic cell-based vaccine confers broad-spectrum antitumor immunity
Read More
Results of HIV-CORE002 trial of HIVconsv vaccines reported
Read More
Discovery of novel EP4 agonists reported by Cayman Chemical Company, Myometrics
Read More
Constellation Pharmaceuticals discovers novel EZH2 inhibitors for cancer
Read More
Kadmon planning phase II trials of KD-025 in three indications
Read More
Helix BioPharma completes interim review of phase I/II study of L-DOS47 in lung cancer
Read More
Synthetic Biologics begins manufacture of SYN-004 for evaluation against C. difficile infections
Read More
Radiotherapy/imaging with trimeric GEBP11 peptide assessed in gastric cancer
Read More
MED12 expression as a prognostic marker in NSCLC
Read More
Johnson & Johnson reviews third quarter 2013
Read More
Lytix Biopharma receives clearance to conduct phase I study of LTX-315
Read More
FDA approves Novoeight for use in adults and children with hemophilia A
Read More
Esteve reports data from phase II study of E-58425 in acute pain
Read More
FDA agrees with Omeros' pediatric study plan for OMS-302
Read More
Hanmi Pharmaceutical advances new biological drug for diabetes to phase IIb trials
Read More
Phase III alirocumab results show efficacy superior to ezetimibe
Read More
RedHill's combination therapy achieves 80% remission in pediatric patients with Crohn's disease
Read More
Dynavax reveals design of phase III trial of hepatitis B vaccine
Read More
FDA committee votes against approval of Vascepa
Read More
FDA extends review of AMAG's sNDA to expand indication for Feraheme
Read More
Scientists at EnVivo Pharmaceuticals patent novel PDE9A inhibitors
Read More
Taiho Pharmaceutical synthesizes new vasopressin receptor antagonists
Read More
New JCV neutralizing antibodies discovered at Biogen Idec
Read More
